| Phase 2 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT07309770 | Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies | Urachal Cancer | Recruiting | 2025-12-30 |
| NCT07046650 | Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin… | Advanced Solid Tumors | Recruiting | 2025-07-01 |
| NCT07095803 | Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple… | Multiple Advanced Tumors After PD-1 Therapy Failure | Not Yet Recruiting | 2025-07-31 |
| Not applicable | ||||
| NCT07164950 | Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates… | Urothelial Carcinoma | Recruiting | 2025-09-15 |
Bladder Cancer (1)